Jeroen van de Pol

180 Chapter 6 References [1] Hazen ACM, Wal AW van der, Sloeserwij VM et al. Controversy and consensus on a clinical pharmacist in primary care in the Netherlands. Int J Clin Pharm. 2016;38:1250–60. [2] Bryant LJM, Coster G, Gamble GD et al. General practitioners’ and pharmacists’ perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm. 2009;5:347–62. [3] Heringa M, Floor-Schreudering A, Wouters H et al. Preferences of Patients and Pharmacists with Regard to the Management of Drug-Drug Interactions: A Choice-Based Conjoint Analysis. Drug Saf. 2018;41(2):179–89. [4] Kooij MJ, Heerdink ER, van Dijk L et al. Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence; Results of a Cluster Randomized Trial. Front Pharmacol. 2016;7:269. [5] Ensing HT, Koster ES, Dubero DJ, van Dooren AA et al. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program. Res Social Adm Pharm. 2019;15(3):267–78. [6] Jokanovic N, Tan EC, Sudhakaran S et al. Pharmacist-led medication review in community settings: An overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–85. [7] Readdean KC, Heuer AJ, Scott Parrott J. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis. Res Social Adm Pharm. 2018;14(4):321–31. [8] Chiu P, Lee A, See T et al. Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients. Hong Kong Med J. 2018;24(2):98–106. [9] VerdoornS, BlomJ, VogelzangTet al. Theuseof goal attainment scalingduring clinicalmedication review in older persons with polypharmacy. Res Social Adm Pharm. 2019;15(10):1259–65. [10] Al Hamarneh YN, Johnston K, Marra CA et al. Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the R(x)EACH study. Can Pharm J (Ott). 2019;152(4):257–66. [11] Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review. Res Social Adm Pharm. 2018;14(8):707–17. [12] Mekonnen AB, McLachlan AJ, Brien J. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta- analysis. BMJ Open. 2016;6(2):e010003. [13] Kotter JP. Leading change. November 6, 2012. ISBN: 978-1-4221-8643-5. [14] Michie S, van StralenMM, West R. The behaviour change wheel: a newmethod for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. [15] Rosenthal M, GrindrodKA, Lynd L, MarraCAet al. Pharmacists’ Perspectives onProviding Chronic Disease Management Services in the Community — Part II: Development and Implementation of Services. Can Pharm J / Rev des Pharm du Canada 20091;142(6):284-8.